跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
iPLEDGE SKIN ADVANCE REJUV - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
iPLEDGE SKIN ADVANCE REJUV
Approved
STANDARD
iPLEDGE SKIN ADVANCE REJUV
Refinette Cosmetic Manufacturing Corporation
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
5edcbd73c033e3c9
Company
Refinette Cosmetic Manufacturing Corporation
Type
Standard
Approval Details
Approval Id
5edcbd73c033e3c9
Drug Approval Philippines Name
iPLEDGE SKIN ADVANCE REJUV
Product Name
iPLEDGE SKIN ADVANCE REJUV
Registration Number
HRP-417-07
Brand Name
iPLEDGE SKIN ADVANCE REJUV
Generic Name
Tretinoin + Hydroquinone
Dosage Form
Topical Solution
Dosage Strength
10 mg/2g per 100 mL (0.01%/2%)
Manufacturer
Refinette Cosmetic Manufacturing Corporation
Distributor
Medispa Skin Clinic & Salon
Issuance Date
24 September 2024
Expiry Date
15 March 2026
Pharmacologic Category
Exfoliant / Anti-Acne / Depigmenting
Classification
Household Remedy (HR)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
5edcbd73c033e3c9
Type
Standard
Back to Philippines FDA Approvals